Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2012

Jul 31, 2012

33431_dirs_2012-07-31_858ba9b0-6f9d-4325-a1de-e6694be5d006.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-07-30

Reporting Person: Hollis Richard Dean (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-07-30 Common Stock M 3333 Acquired 6667 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-07-30 Restricted Stock Units $ M 3333 Disposed 2012-07-30 Common Stock (3333) Direct

Footnotes

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: The restricted stock units were granted on July 30, 2009.

F3: The restricted stock units vested on July 30, 2012.